The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation

Osteoporos Int. 2000;11 Suppl 6:S2-17. doi: 10.1007/s001980070002.
No abstract available

Publication types

  • Guideline
  • Practice Guideline
  • Review

MeSH terms

  • Biomarkers* / blood
  • Biomarkers* / urine
  • Bone Density / physiology
  • Bone Regeneration / physiology
  • Bone Remodeling / physiology*
  • Bone Resorption / metabolism
  • Diphosphonates / therapeutic use
  • Estrogens / therapeutic use
  • Female
  • Fractures, Spontaneous / diagnosis
  • Fractures, Spontaneous / etiology
  • Fractures, Spontaneous / prevention & control
  • Humans
  • Osteoporosis / diagnosis*
  • Osteoporosis / drug therapy
  • Osteoporosis / physiopathology
  • Osteoporosis, Postmenopausal / diagnosis
  • Osteoporosis, Postmenopausal / drug therapy
  • Osteoporosis, Postmenopausal / physiopathology
  • Periodicity
  • Prognosis
  • Raloxifene Hydrochloride / therapeutic use
  • Risk Assessment
  • Terminology as Topic

Substances

  • Biomarkers
  • Diphosphonates
  • Estrogens
  • Raloxifene Hydrochloride